LBRX

LB Pharmaceuticals Inc Common StockNASDAQHealthcare

$25.69+3.55%ClosedMarket Cap: $649.9M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

2.26

P/S

0.00

EV/EBITDA

-15.71

DCF Value

$9.67

FCF Yield

-5.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-19.5%

ROA

-8.1%

ROIC

-9.9%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$0.00	-Infinity%	$-13.9M	$-11.5M	$-0.45	—
FY 2025	$0.00	-Infinity%	$-30.4M	$-25.2M	$-1.00	—
Q3 2025	$0.00	-Infinity%	$-5.2M	$-3.6M	$-0.14	—
Q2 2025	$0.00	NaN%	$-5.6M	$-5.1M	$-20.21	—
Q1 2025	$0.00	NaN%	$-5.6M	$-5.1M	$-20.21	—
FY 2024	$0.00	NaN%	$-64.8M	$-63.1M	$-17.83	—
Q3 2024	$0.00	-Infinity%	$-16.1M	$-14.2M	$-0.63	—
Q2 2024	$0.00	NaN%	$-26.6M	$-27.7M	$-7.82	—
Q1 2024	$0.00	NaN%	$-16.6M	$-16.2M	$-4.56	—
FY 2023	$0.00	NaN%	$-11.4M	$-6.3M	$-1.77	—
FY 2022	$0.00	NaN%	$-2.8M	$-14.3M	$-4.05	—